Seshadri
Seshadri Harinarayanan, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20120089852 | ENERGY OPTIMIZATION TECHNIQUES IN A COMPUTING SYSTEM - A computing platform may include components to determine performance loss values and energy savings values for each of the plurality of regions and/or the memory boundedness value of each of a plurality of regions within an application. The computing platform may provide a user interface for a user to provide a user input, which provides an indication of an acceptable performance loss. For the provided performance loss value, the frequency values may be determined and the processing element may be operated at the frequency values while processing each of the plurality of regions. | 04-12-2012 |
Seshadri Harinipriya, Jodhpur IN
Patent application number | Description | Published |
---|---|---|
20140326917 | INK COMPOSITION - An ink composition for printing on a substrate is disclosed. The ink composition comprises a conductive material, ethyl cellulose as a binder; and a solvent selected from the group consisting of isoamylacetate and isoamylacetate-water mixture. | 11-06-2014 |
Seshadri Neervannan, Thousand Oaks, CA US
Patent application number | Description | Published |
---|---|---|
20100331548 | SOLID-STATE FORM OF AMG 706 AND PHARMACEUTICAL COMPOSITIONS THEREOF - The anti-angiogenic drug AMG 706 is provided in amorphous form. Also provided is AMG 706 drug substance wherein the AMG 706 is present, in at least a detectable amount, as amorphous AMG 706. Also provided is an AMG 706-crystallization inhibitor composite comprising particles of amorphous AMG 706 or a AMG 706 drug substance of the invention in intimate association with one or more crystallization inhibitors, for example polymers. Also provided is a pharmaceutical composition comprising such an AMG 706-crystallization inhibitor composite and one or more excipients. Also provided are processes for preparing amorphous AMG 706, AMG 706 drug substance of the invention, an AMG 706-crystallization inhibitor composite of the invention, and a pharmaceutical composition of the invention. Also provided is a method of treating a medical condition or disorder in a subject where treatment with an anti-angiogenic is indicated, comprising administering, for example orally, a composition of the invention in a therapeutically effective amount. | 12-30-2010 |
Seshadri Rajamannar, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20120011408 | GRAPHICAL USER INTERFACE SYSTEM FOR BACKGROUND INTELLIGENT TRANSFER SERVICE - A graphical user interface system for BITS. The system includes a set of input modules, a set of output modules, and notification modules. The set of input modules allow selection of files for transfer to the BITS Server Virtual Directory and activate BITS functions. The BITS functions may include starting file transfer, cancelling file transfer, retrying file transfer, or removing the selected files. The set of output modules show dynamic status and real-time progress of the transfer automatically upon activation of the transfer of the selected files. The set of output modules also display an error message upon detecting an error in the transfer. Further, the notification modules provide a real-time notification on completion of the transfer. | 01-12-2012 |
Seshadri Subbanna, Brewster, NY US
Patent application number | Description | Published |
---|---|---|
20120295417 | SELECTIVE EPITAXIAL GROWTH BY INCUBATION TIME ENGINEERING - A method of controlling the nucleation rate (i.e., incubation time) of dissimilar materials in an epitaxial growth chamber that can favor high growth rates and can be compatible with low temperature growth is provided. The nucleation rate of dissimilar materials is controlled in an epitaxial growth chamber by altering the nucleation rate for the growth of a given material film, relative to single crystal growth of the same material film, by choosing an appropriate masking material with a given native nucleation characteristic, or by modifying the surface of the masking layer to achieve the appropriate nucleation characteristic. Alternatively, nucleation rate control can be achieved by modifying the surface of selected areas of a semiconductor substrate relative to other areas in which an epitaxial semiconductor material will be subsequently formed. | 11-22-2012 |
Seshadri Tirunillai, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20120316917 | EXTRACTING DIMENSIONS OF QUALITY FROM ONLINE USER-GENERATED CONTENT - The quality of a product may be an important driver of consumer satisfaction, competition, and long-term brand success. Identifying the right dimensions of product quality may be central to devising segmentation and positioning strategies, rankings brands, creating advertising content, improving current products, or designing new products. User-generated content, such as product reviews, may identify quality. Data in product reviews is analyzed across fifteen firms in five markets over four years to extract the dimensions of experienced quality using Latent Dirichlet Allocation. The face, external, and predictive validity of these dimensions is explored. Results suggest that a few dimensions may be enough to capture experienced quality, have good correspondence to other metrics of quality, and serve as reasonably good predictors of earnings and stock market returns. Dynamic analysis may enable tracking the importance of dimensions and of competitive brand positions on those dimensions over time. | 12-13-2012 |